13F filer · CIK 1658437
Puissance Capital Management LP
NEW YORK, NY · filing since Q4 2017 · last filing Nov 12, 2020
Reported value
$17.3M
$-6.1M vs prior
Positions
5
New / sold out
2 / 1
Added / reduced
0 / 0
Turnover
8.7%
buys $1.8M · sells $2.3M
Top-10 weight
100.0%
Biggest buys vs Q2 2020
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | SCYNEXIS INC | +311,143 | – | +$1.4M |
| New | KADMON HLDGS INC | +100,184 | – | +$393.0K |
Biggest sells vs Q2 2020
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | SCYNEXIS INC | -3,111,436 | -100.0% | $-2.3M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2020
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | BELLEROPHON THERAPEUTICS INCCOM NEW | 1,153,846 | $11.7M | 67.74% |
| 2 | EKSO BIONICS HLDGS INCCOM | 774,400 | $3.7M | 21.21% |
| 3 | SCYNEXIS INCCOM NEW | 311,143 | $1.4M | 7.91% |
| 4 | KADMON HLDGS INCCOM | 100,184 | $393.0K | 2.27% |
| 5 | CORVUS PHARMACEUTICALS INCCOM | 38,010 | $152.0K | 0.88% |